Listed

Lipocine Inc.

LPCNNasdaqCIK 1535955HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$190.1k, Q2 FY2026
Operating income−$2.8m, Q2 FY2026
Net income−$2.6m, Q2 FY2026
Lipocine Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k(3,122)Revenue, Q3 FY2023, three months to 2023-09-30−$3.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure216Revenue, Q4 FY2023, three months to 2023-12-31$216.2k. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figure7,617Revenue, Q1 FY2024, three months to 2024-03-31$7.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure89.6Revenue, Q2 FY2024, three months to 2024-06-30$89.6k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001493152-25-021007. Derived: 9-month figure less the 6-month figure.Report this figure3,491Revenue, Q4 FY2024, three months to 2024-12-31$3.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure93.9Revenue, Q1 FY2025, three months to 2025-03-31$93.9k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure623Revenue, Q2 FY2025, three months to 2025-06-30$622.8k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure115Revenue, Q3 FY2025, three months to 2025-09-30$114.6k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure1,145Revenue, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure119Revenue, Q1 FY2026, three months to 2026-03-31$119.4k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure190Revenue, Q2 FY2026, three months to 2026-06-30$190.1k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Research and development$k2,879Research and development, Q3 FY2023, three months to 2023-09-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure1,675Research and development, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figure2,819Research and development, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure1,875Research and development, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure1,585Research and development, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure1,073Research and development, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure1,062Research and development, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure2,137Research and development, Q2 FY2025, three months to 2025-06-30$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure2,708Research and development, Q3 FY2025, three months to 2025-09-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure2,678Research and development, Q4 FY2025, three months to 2025-12-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure2,764Research and development, Q1 FY2026, three months to 2026-03-31$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure2,041Research and development, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Operating income$k(7,043)Operating income, Q3 FY2023, three months to 2023-09-30−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure(2,593)Operating income, Q4 FY2023, three months to 2023-12-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figure3,223Operating income, Q1 FY2024, three months to 2024-03-31$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure(3,293)Operating income, Q2 FY2024, three months to 2024-06-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure(2,630)Operating income, Q3 FY2024, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure1,545Operating income, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure(2,090)Operating income, Q1 FY2025, three months to 2025-03-31−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(2,404)Operating income, Q2 FY2025, three months to 2025-06-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure(3,361)Operating income, Q3 FY2025, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure(2,516)Operating income, Q4 FY2025, three months to 2025-12-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure(3,849)Operating income, Q1 FY2026, three months to 2026-03-31−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(2,842)Operating income, Q2 FY2026, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$k0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001493152-24-043893. Derived: 9-month figure less the 6-month figure.Report this figure0.6Income tax, Q4 FY2023, three months to 2023-12-31$555. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$200. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure0.5Income tax, Q2 FY2024, three months to 2024-06-30$481. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001493152-25-021007. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2025, three months to 2025-03-31$200. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001493152-26-035909. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001493152-25-021007. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.2Income tax, Q2 FY2026, three months to 2026-06-30$200. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Net income$k(6,651)Net income, Q3 FY2023, three months to 2023-09-30−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure(2,282)Net income, Q4 FY2023, three months to 2023-12-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figure3,514Net income, Q1 FY2024, three months to 2024-03-31$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure(3,069)Net income, Q2 FY2024, three months to 2024-06-30−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure(2,219)Net income, Q3 FY2024, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure1,782Net income, Q4 FY2024, three months to 2024-12-31$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure(1,865)Net income, Q1 FY2025, three months to 2025-03-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(2,206)Net income, Q2 FY2025, three months to 2025-06-30−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure(3,187)Net income, Q3 FY2025, three months to 2025-09-30−$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure(2,370)Net income, Q4 FY2025, three months to 2025-12-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure(3,672)Net income, Q1 FY2026, three months to 2026-03-31−$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(2,623)Net income, Q2 FY2026, three months to 2026-06-30−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Diluted EPS$ per share(1.27)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figurenot reported0.66Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure(0.56)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure(0.44)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(0.41)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure(0.59)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(0.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Basic EPS$ per share(1.26)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figurenot reported0.66Basic EPS, Q1 FY2024, three months to 2024-03-31$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure(0.57)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure(0.41)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figurenot reported(0.35)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(0.41)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure(0.59)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figurenot reported(0.54)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(0.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure

Balance sheet

Cash and equivalents$5.0m, Q2 FY2026
Shareholders' equity$21.8m, Q2 FY2026
Lipocine Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m4.1Cash and equivalents, Q3 FY2023, at 2023-09-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001493152-23-039861.Report this figure4.8Cash and equivalents, FY2023, at 2023-12-31$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0001493152-25-010146.Report this figure3.1Cash and equivalents, Q1 FY2024, at 2024-03-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001493152-24-018311.Report this figure5.6Cash and equivalents, Q2 FY2024, at 2024-06-30$5.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001493152-24-030648.Report this figure3.7Cash and equivalents, Q3 FY2024, at 2024-09-30$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure6.2Cash and equivalents, FY2024, at 2024-12-31$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001493152-26-009411.Report this figure3.4Cash and equivalents, Q1 FY2025, at 2025-03-31$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure6.0Cash and equivalents, Q2 FY2025, at 2025-06-30$6.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure3.9Cash and equivalents, Q3 FY2025, at 2025-09-30$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure5.2Cash and equivalents, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure5.0Cash and equivalents, Q1 FY2026, at 2026-03-31$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure5.0Cash and equivalents, Q2 FY2026, at 2026-06-30$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Current assets$m24.6Current assets, Q3 FY2023, at 2023-09-30$24.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001493152-23-039861.Report this figure22.9Current assets, FY2023, at 2023-12-31$22.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0001493152-25-010146.Report this figure25.3Current assets, Q1 FY2024, at 2024-03-31$25.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018311.Report this figure22.9Current assets, Q2 FY2024, at 2024-06-30$22.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030648.Report this figure20.5Current assets, Q3 FY2024, at 2024-09-30$20.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure22.3Current assets, FY2024, at 2024-12-31$22.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001493152-26-009411.Report this figure20.3Current assets, Q1 FY2025, at 2025-03-31$20.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure18.4Current assets, Q2 FY2025, at 2025-06-30$18.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure15.9Current assets, Q3 FY2025, at 2025-09-30$15.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure16.9Current assets, FY2025, at 2025-12-31$16.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure25.2Current assets, Q1 FY2026, at 2026-03-31$25.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure23.7Current assets, Q2 FY2026, at 2026-06-30$23.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Total assets$m24.8Total assets, Q3 FY2023, at 2023-09-30$24.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001493152-23-039861.Report this figure23.0Total assets, FY2023, at 2023-12-31$23.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0001493152-25-010146.Report this figure25.4Total assets, Q1 FY2024, at 2024-03-31$25.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001493152-24-018311.Report this figure23.0Total assets, Q2 FY2024, at 2024-06-30$23.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001493152-24-030648.Report this figure20.7Total assets, Q3 FY2024, at 2024-09-30$20.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure22.5Total assets, FY2024, at 2024-12-31$22.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001493152-26-009411.Report this figure20.5Total assets, Q1 FY2025, at 2025-03-31$20.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure18.6Total assets, Q2 FY2025, at 2025-06-30$18.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure16.1Total assets, Q3 FY2025, at 2025-09-30$16.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure17.0Total assets, FY2025, at 2025-12-31$17.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure25.4Total assets, Q1 FY2026, at 2026-03-31$25.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure23.8Total assets, Q2 FY2026, at 2026-06-30$23.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Current liabilities$m2.2Current liabilities, Q3 FY2023, at 2023-09-30$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001493152-23-039861.Report this figure2.6Current liabilities, FY2023, at 2023-12-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0001493152-25-010146.Report this figure1.5Current liabilities, Q1 FY2024, at 2024-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001493152-24-018311.Report this figure1.8Current liabilities, Q2 FY2024, at 2024-06-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001493152-24-030648.Report this figure1.6Current liabilities, Q3 FY2024, at 2024-09-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure1.5Current liabilities, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001493152-26-009411.Report this figure1.3Current liabilities, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure1.4Current liabilities, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure1.9Current liabilities, Q3 FY2025, at 2025-09-30$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure2.5Current liabilities, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure2.5Current liabilities, Q1 FY2026, at 2026-03-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure2.1Current liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Total liabilities$m2.3Total liabilities, Q3 FY2023, at 2023-09-30$2.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001493152-23-039861.Report this figure2.6Total liabilities, FY2023, at 2023-12-31$2.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0001493152-25-010146.Report this figure1.5Total liabilities, Q1 FY2024, at 2024-03-31$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001493152-24-018311.Report this figure1.8Total liabilities, Q2 FY2024, at 2024-06-30$1.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001493152-24-030648.Report this figure1.6Total liabilities, Q3 FY2024, at 2024-09-30$1.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure1.5Total liabilities, FY2024, at 2024-12-31$1.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001493152-26-009411.Report this figure1.3Total liabilities, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure1.4Total liabilities, Q2 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure1.9Total liabilities, Q3 FY2025, at 2025-09-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure2.5Total liabilities, FY2025, at 2025-12-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure2.5Total liabilities, Q1 FY2026, at 2026-03-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure2.1Total liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m22.5Shareholders' equity, Q3 FY2023, at 2023-09-30$22.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure20.4Shareholders' equity, FY2023, at 2023-12-31$20.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001493152-26-009411.Report this figure24.0Shareholders' equity, Q1 FY2024, at 2024-03-31$24.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure21.2Shareholders' equity, Q2 FY2024, at 2024-06-30$21.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure19.1Shareholders' equity, Q3 FY2024, at 2024-09-30$19.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure21.0Shareholders' equity, FY2024, at 2024-12-31$21.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure19.2Shareholders' equity, Q1 FY2025, at 2025-03-31$19.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure17.1Shareholders' equity, Q2 FY2025, at 2025-06-30$17.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure14.1Shareholders' equity, Q3 FY2025, at 2025-09-30$14.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure14.5Shareholders' equity, FY2025, at 2025-12-31$14.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure22.8Shareholders' equity, Q1 FY2026, at 2026-03-31$22.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure21.8Shareholders' equity, Q2 FY2026, at 2026-06-30$21.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure

Cash flow

Operating cash flow−$3.0m, Q2 FY2026
Capital expenditure$10.0k, Q4 FY2024
Share repurchases$8.1k, Q1 FY2024
Lipocine Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,606)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001493152-24-043893. Derived: 9-month figure less the 6-month figure.Report this figure(2,022)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figure2,408Operating cash flow, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure(2,498)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001493152-25-011588. Derived: 6-month figure less the 3-month figure.Report this figure(2,833)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001493152-25-021007. Derived: 9-month figure less the 6-month figure.Report this figure1,702Operating cash flow, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure(1,969)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(1,886)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001493152-26-035909. Derived: 6-month figure less the 3-month figure.Report this figure(2,986)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001493152-25-021007. Derived: 9-month figure less the 6-month figure.Report this figure(2,920)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figure(2,257)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure(3,028)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001493152-26-035909. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001493152-24-043893. Derived: 9-month figure less the 6-month figure.Report this figure9.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$9.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0001493152-25-010146. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reported10.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001493152-26-009411. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$knot reportednot reported8.1Share repurchases, Q1 FY2024, three months to 2024-03-31$8.1k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)8.22m, Q2 FY2026
Lipocine Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares5,250Diluted shares (weighted), Q3 FY2022, three months to 2022-09-305,250,179 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001493152-23-039861.Report this figure5,235Diluted shares (weighted), Q1 FY2023, three months to 2023-03-315,234,830 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001493152-24-018311.Report this figure5,235Diluted shares (weighted), Q2 FY2023, three months to 2023-06-305,234,830 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001493152-24-030648.Report this figure5,292Diluted shares (weighted), Q3 FY2023, three months to 2023-09-305,292,058 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001493152-24-043893.Report this figure5,358Diluted shares (weighted), Q1 FY2024, three months to 2024-03-315,357,530 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001641172-25-009180.Report this figure5,344Diluted shares (weighted), Q2 FY2024, three months to 2024-06-305,343,922 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001493152-25-011588.Report this figure5,348Diluted shares (weighted), Q3 FY2024, three months to 2024-09-305,347,940 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure5,349Diluted shares (weighted), Q1 FY2025, three months to 2025-03-315,348,557 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure5,352Diluted shares (weighted), Q2 FY2025, three months to 2025-06-305,351,957 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure5,413Diluted shares (weighted), Q3 FY2025, three months to 2025-09-305,413,149 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001493152-25-021007.Report this figure6,795Diluted shares (weighted), Q1 FY2026, three months to 2026-03-316,795,002 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001493152-26-021637.Report this figure8,217Diluted shares (weighted), Q2 FY2026, three months to 2026-06-308,216,988 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure

Shares outstanding: 8.24mShares outstanding, period not labelled, at 2026-08-038,244,253 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001493152-26-035909.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.